Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medicinova (MNOV) Non-Current Deferred Tax Liability (2021 - 2025)

Medicinova (MNOV) has disclosed Non-Current Deferred Tax Liability for 8 consecutive years, with $201792.0 as the latest value for Q4 2025.

  • Quarterly Non-Current Deferred Tax Liability changed N/A to $201792.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $201792.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $201792.0 for FY2025, N/A changed from the prior year.
  • Non-Current Deferred Tax Liability for Q4 2025 was $201792.0 at Medicinova, roughly flat from $201792.0 in the prior quarter.
  • The five-year high for Non-Current Deferred Tax Liability was $201792.0 in Q1 2021, with the low at $201792.0 in Q1 2021.
  • Average Non-Current Deferred Tax Liability over 5 years is $201792.0, with a median of $201792.0 recorded in 2021.
  • Peak annual rise in Non-Current Deferred Tax Liability hit 0.0% in 2022, while the deepest fall reached 0.0% in 2022.
  • Over 5 years, Non-Current Deferred Tax Liability stood at $201792.0 in 2021, then changed by 0.0% to $201792.0 in 2022, then changed by 0.0% to $201792.0 in 2023, then changed by 0.0% to $201792.0 in 2024, then changed by 0.0% to $201792.0 in 2025.
  • According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods came in at $201792.0, $201792.0, and $201792.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.